Position in RDY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,362,476
+$674,251 QoQ
Shares Held
170,576
+41.9% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 0%
Shared 4%
None 96%
Common Shares in RDY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026WELLINGTON MANAGEMENT GROUP LLP holds $3,311,744,758 across 31 Drug Manufacturers - Specialty & Generic names. RDY ranks #17 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
2,264,247 | $1,342,653,181 | |
| 2 | ZTS |
Zoetis Inc.
|
10,150,096 | $1,199,842,846 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
7,251,828 | $218,425,057 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
1,389,539 | $183,057,866 | |
| 5 | ALKS |
Alkermes plc.
|
2,970,166 | $105,025,067 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
3,035,856 | $72,648,032 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
768,850 | $58,317,270 | |
| 8 | HLN |
Haleon plc
|
4,828,648 | $48,334,765 |
All Filings in RDY
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,362,476 | 170,576 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,688,225 | 120,244 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,681,010 | 120,244 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $10,519,029 | 699,869 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $8,547,911 | 648,060 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $14,150,445 | 896,165 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $13,387,325 | 168,500 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $13,304,069 | 174,617 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $10,887,193 | 148,428 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $10,050,483 | 144,445 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $1,887,793 | 141,154 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $6,331,763 | 100,329 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,968,500 | 52,143 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,107,777 | 40,730 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,174,038 | 22,431 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,242,453 | 22,431 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,250,079 | 22,431 | Shares | Defined | 2022-05-16 | |
| 2021-03-31 | $5,952,558 | 96,963 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $20,184,835 | 283,137 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $22,956,258 | 330,021 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $19,925,556 | 375,883 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $20,054,495 | 497,260 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||